![]() | |
Names | |
---|---|
IUPAC name tert-Butyl 8-methyl-7-oxo-5-thia-1,8,12-triazatricyclo[8.3.0.02,6]trideca-2(6),3,10,12-tetraene-11-carboxylate | |
Identifiers | |
3D model (JSmol) | |
ChEBI | |
ChEMBL | |
ChemSpider | |
KEGG | |
PubChem CID | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C15H17N3O3S | |
Molar mass | 319.38 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Ro 19-4603 is an inverse agonist of the benzodiazepine binding site. It has effects antagonistic to those of benzodiazepines.
Despite acting at the benzodiazepine site, it does not possess the benzodiazepine structure. It is an imidazothienodiazepine: a thiophene ring, an imidazole ring, and a diazepine ring fused together.
Ro 19-4603 is an inverse agonist at the benzodiazepine binding site. Due to this, it has effects similar to other benzodiazepine inverse agonists, notably: anxiogenesis [2] and convulsions. [3]
In animal studies, administration of this compound was able to decrease voluntary alcohol consumption. This was observed in rats selected for high alcohol preference. [4] In addition to decreasing its consumption, Ro 19-4603 is able to antagonize the intoxicating effects of alcohol. [5]